Clinical Trial Update: Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome [Phase 1]

View source ↗

Summary

Phase 1 study evaluating eleclazine on QT interval, safety, and tolerability in participants with Long QT Type 2 syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Qt Syndrome Type

Drugs mentioned

• Eleclazine (Eleclazine)

Snippet

Sponsor: Gilead Sciences | Conditions: LQT2 Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2020-12-30